Related Experiment Video
Updated: Jun 13, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Epigenetic alterations in myelodysplastic syndromes]
1Department of Hematology, The Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200233, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|April 27, 2010
Summary
Epigenetic alterations, like DNA methylation, drive cancer by silencing tumor suppressor genes. These changes are crucial in myelodysplastic syndromes (MDS) and may offer future diagnostic and prognostic biomarkers.
Area of Science:
- Epigenetics and Molecular Oncology
- Gene Regulation and Cancer Biology
Context:
- Epigenetic alterations, including DNA promoter methylation and histone modifications, are heritable changes in gene expression without altering DNA sequence.
- These modifications can lead to the inactivation of tumor suppressor genes, a critical factor in cancer development.
- Myelodysplastic syndromes (MDS) are characterized by numerous epigenetic alterations, such as key gene promoter methylation and Polycomb group (PcG) gene abnormalities.
Purpose:
- To review the molecular basis of epigenetic alterations in myelodysplastic syndromes.
- To discuss the inactivation of suppressor genes and abnormal expression of PcG in MDS.
- To highlight the potential of epigenetic alterations as biomarkers for MDS detection, status evaluation, and prognosis.
Summary:
- Epigenetic alterations, involving DNA methylation and histone modifications, contribute to cancer by silencing tumor suppressor genes.
- MDS exhibits significant epigenetic changes, including promoter methylation and PcG aberrancies, impacting disease progression and prognosis.
- The review covers the molecular mechanisms underlying these epigenetic changes in MDS.
Impact:
- Understanding epigenetic alterations in MDS is crucial for developing targeted therapies.
- Epigenetic modifications show promise as valuable biomarkers for early detection and prognosis assessment in MDS.
- This review provides insights into the role of epigenetics in MDS pathogenesis and clinical applications.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:30Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...